ArticleCell death discovery2022

Targeting NOX4 disrupts the resistance of papillary thyroid carcinoma to chemotherapeutic drugs and lenvatinib.

Ping Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.